Citadel Advisors’s Zivo Bioscience, Inc. Warrants ZIVOW Stock Holding History
Bought
Maintained
Sold
Citadel Advisors's ZIVOW Position: Q4 2023 in Review
Citadel Advisors sold out of Zivo Bioscience, Inc. Warrants (ZIVOW) in Q4 2023, closing a stake of 17,798 shares — an estimated $7.97K sold.
Citadel Advisors first reported a position in ZIVOW in Q2 2023 and held it in 2 quarters. The position peaked at $7.97K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZIVOW as of Q4 2023.
- Citadel Advisors reported no remaining Zivo Bioscience, Inc. Warrants position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 17,798 Zivo Bioscience, Inc. Warrants shares in Q4 2023, an estimated $7.97K.
- Citadel Advisors first reported a position in Zivo Bioscience, Inc. Warrants in Q2 2023 and held it in 2 quarters.
- Citadel Advisors's Zivo Bioscience, Inc. Warrants position peaked at $7.97K in Q3 2023.
- 0 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Warrants as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.